Biologics-in-Africa

Do you have an idea for The New Times to cover? Submit it here!
Search Results for "Biologics-in-Africa" (12 articles)
A section of Kigali Central Business District at Imbuga City Walk in Nyarugenge District, on Monday, May 11. Photo by Craish Bahizi

Rwanda’s emerging role in global cancer innovation

Tuesday, May 12, 2026
Rwandan-owned biopharmaceutical platform, AKAGERA Medicines was built to translate this philosophy into practice—advancing the discovery, development, and manufacturing of vaccines and biologics.

When the lights flicker: From aid dependency to African ownership

Thursday, May 07, 2026
Vaccines and biologics need to be stored within a narrow temperature range, typically between 2°C and 8°C, from production to administration. File

The cost of cold chain failures in global health delivery

Friday, April 17, 2026
A scientist endeavoring to develop a vaccine for TB.

TB risk should not depend on where we are born

Tuesday, March 24, 2026
psoriasis, a chronic skin disease
Health

Skin conditions: Psoriasis patients speak out on stigma and neglect

Tuesday, November 04, 2025
Dr. Menghis Bairu (L) is President & CEO of biotech company Bio Usawa, whereas Prof. Wanjiku Mathenge (R) is a renowned ophthalmologist in Africa.

Rwanda’s approval of first eye care biosimilar offers hope for millions

Thursday, October 23, 2025
No Image
play icon
Health

IVI Africa’s Ndembi on Rwanda’s role in vaccine innovation and health security

Monday, July 21, 2025
L-R: Menghis Bairu, the President and CEO of Bio Usawa, Delese Mimi Darko, the Managing Director of the African Medicines Agency, and Nicaise Ndembi, the Deputy Director General of the Africa Regional Office of the International Vaccine Institute. All three organizations are headquartered in Kigali.

How Kigali is becoming Africa’s biopharma capital

Saturday, July 05, 2025
BasiGo and AC Mobility aim to deliver 200 electric buses to bus operators in the country Courtesy
Economy

Top investment projects registered in Rwanda in 2024

Monday, April 21, 2025
Menghis Bairu, the Chief Executive Officer of Bio Usawa and Francis Gatare, Rwanda Development Board's Chief Executive Officer in February 2024. Courtesy
Health

Rwanda, Bio Usawa ink deal to manufacture affordable eye treatments in Africa

Friday, November 22, 2024
President Paul Kagame with several Heads of State and Government and other senior delegates offically launch BioNTech’s first vaccine manufacturing plant in Africa on Monday,December 18 . Photo by Olivier Mugwiza
Health

Rwanda unveils BioNTech’s first vaccine manufacturing plant in Africa

Monday, December 18, 2023
The New Times

Rwanda closer to vaccine production

Thursday, July 29, 2021